157 related articles for article (PubMed ID: 4374289)
1. Long-term infusion of growth hormone release inhibiting hormone in acromegaly: effects on pituitary and pancreatic hormones.
Besser GM; Mortimer CH; McNeilly AS; Thorner MO; Batistoni GA; Bloom SR; Kastrup KW; Hanssen KF; Hall R; Coy DH; Kastin AJ; Schally AV
Br Med J; 1974 Dec; 4(5945):622-7. PubMed ID: 4374289
[TBL] [Abstract][Full Text] [Related]
2. Effect of somatostatin in patients with acromegaly: suppression of growth hormone, prolactin, insulin and glucose levels.
Yen SS; Siler TM; DeVane GW
N Engl J Med; 1974 Apr; 290(17):935-8. PubMed ID: 4593614
[No Abstract] [Full Text] [Related]
3. Effect of bromocriptine on serum hormones in acromegaly.
Carlson HE; Levin SR; Braunstein GD; Spencer EM; Wilson SE; Hershman JM
Horm Res; 1984; 19(3):142-52. PubMed ID: 6425186
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone and somatomedin levels in acromegalics treated with bromocriptine.
Shalet SM; Price DA; Beardwell CG; Mindel A; MacFarlane IA
Horm Res; 1980; 12(3):121-9. PubMed ID: 6768666
[No Abstract] [Full Text] [Related]
5. Growth hormone release inhibiting hormone in acromegaly.
Besser GM; Mortimer CH; Carr D; Schally AV; Coy DH; Evered D; Kastin AJ; Tunbridge WM; Thorner MO; Hall R
Br Med J; 1974 Mar; 1(5904):352-5. PubMed ID: 4594581
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW
Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339
[TBL] [Abstract][Full Text] [Related]
7. Pituitary and extrapituitary effects of somatostatin in normal man.
Copinschi G; Leclercq-Meyer V; Virasoro E; L'Hermite M; Vanhaelst L; Golstein J; Leclercq R; Féry F; Robyn C
Horm Metab Res; 1976 May; 8(3):226-31. PubMed ID: 181309
[TBL] [Abstract][Full Text] [Related]
8. The influence of bromocriptine on serum levels of growth hormone and other pituitary hormones and its metabolic effects in active acromegaly.
Roelfsema F; Goslings BM; Frölich M; Moolenaar AJ; Seters AP; Van Slooten H
Clin Endocrinol (Oxf); 1979; 11(2):235-44. PubMed ID: 114344
[TBL] [Abstract][Full Text] [Related]
9. [The effect of synthetic somatostatin in normal and acromegalic males].
Wiegelmann W; Solbach HG; Kley HK; Rudorff KH; Herrmann J; Zimmermann H; Krüskemper HL
Dtsch Med Wochenschr; 1975 Feb; 100(8):331-4. PubMed ID: 1090428
[TBL] [Abstract][Full Text] [Related]
10. Influence of L-prolyl-L-leucyl-glycine amide on growth hormone secretion in normal and acromegalic subjects.
Faglia G; Paracchi A; Ferrari C; Beck-Peccoz P; Ambrosi B; Travaglini P; Spada A; Oliver C
J Clin Endocrinol Metab; 1976 May; 42(5):991-4. PubMed ID: 5465
[TBL] [Abstract][Full Text] [Related]
11. Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients.
Mortimer CH; Tunbridge WM; Carr D; Yeomans L; Lind T; Coy DH; Bloom SR; Kastin A; Mallinson CN; Besser GM; Schally AV; Hall R
Lancet; 1974 Apr; 1(7860):697-701. PubMed ID: 4132421
[No Abstract] [Full Text] [Related]
12. Recovery from paradoxical growth hormone responses in acromegaly after transphenoidal selective adenomectomy.
Hoyte KM; Martin JB
J Clin Endocrinol Metab; 1975 Oct; 41(4):656-9. PubMed ID: 809457
[TBL] [Abstract][Full Text] [Related]
13. Effects of human pancreatic growth hormone-releasing factor-40 on serum growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and somatomedin-C concentrations in normal women throughout the menstrual cycle.
Evans WS; Borges JL; Vance ML; Kaiser DL; Rogol AD; Furlanetto R; Rivier J; Vale W; Thorner MO
J Clin Endocrinol Metab; 1984 Nov; 59(5):1006-10. PubMed ID: 6434583
[TBL] [Abstract][Full Text] [Related]
14. Rapid sequential intravenous administration of four hypothalamic releasing hormones as a combined anterior pituitary function test in normal subjects.
Sheldon WR; DeBold CR; Evans WS; DeCherney GS; Jackson RV; Island DP; Thorner MO; Orth DN
J Clin Endocrinol Metab; 1985 Apr; 60(4):623-30. PubMed ID: 2982903
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the effect of levodopa and somatostatin on the plasma levels of growth hormone, insulin, glucagon and prolactin in acromegaly.
Dunn PJ; Donald RA; Espiner EA
Clin Endocrinol (Oxf); 1976 Mar; 5(2):167-74. PubMed ID: 1269163
[TBL] [Abstract][Full Text] [Related]
16. Changes in plasma melanocyte-stimulating hormone, ACTH, prolactin, GH, LH, FSH, and thyroid-stimulating hormone in response to injection of sulpiride, thyrotropin-releasing hormone, or vehicle in insulin-sensitive and -insensitive mares.
Valencia NA; Thompson DL; Mitcham PB
Domest Anim Endocrinol; 2013 May; 44(4):204-12. PubMed ID: 23571008
[TBL] [Abstract][Full Text] [Related]
17. A case of acromegaly improved by pituitary apoplexy.
Abe K; Hirata Y
Endocrinol Jpn; 1975 Apr; 22(2):181-6. PubMed ID: 168061
[TBL] [Abstract][Full Text] [Related]
18. Endocrine effects of naloxone-induced opiate receptor blockade.
Morley JE; Baranetsky NG; Wingert TD; Carlson HE; Hershman JM; Melmed S; Levin SR; Jamison KR; Weitzman R; Chang RJ; Varner AA
J Clin Endocrinol Metab; 1980 Feb; 50(2):251-7. PubMed ID: 6243662
[No Abstract] [Full Text] [Related]
19. Childhood acromegaly: successful therapy with conventional radiation and effects of chlorpromazine on growth hormone and prolactin secretion.
AvRuskin TW; Sau K; Tang S; Juan C
J Clin Endocrinol Metab; 1973 Sep; 37(3):380-8. PubMed ID: 4206490
[No Abstract] [Full Text] [Related]
20. Editorial: Somatostatin: newcomer from the hypothalamus.
Brazeau P; Gullemin R
N Engl J Med; 1974 Apr; 290(17):963-4. PubMed ID: 4206096
[No Abstract] [Full Text] [Related]
[Next] [New Search]
